Tasly Pharmaceutical Group Co. Ltd.
600535Pharmaceuticals
CN¥13.61−0.51%As of Oct 29vs prior close
- Market cap
- $3.1B
- P/E (TTM)
- 16.6×
- P/E (FY1)
- 16.2×
- From 52W high
- −15.57%
- EPS (LTM)
- CN¥0.82
- Revenue (LTM)
- CN¥8B
- Net margin
- 15.29%
Nomior Score
47
Steady ProfileBottom 42% of the scored universe
Growth43
Quality56
Value44
Momentum30
Resilience71
Growth
−1.57%revenue a year over 3 fiscal years
YE22 CN¥8.6BLTM CN¥8B
Connections
Revenue to profitYE25
13% of revenue became net profit, up 2 pts on a year.